Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

SHA:600572 Revenue

Zhejiang CONBA Pharmaceutical had revenue of 1.80B CNY in the quarter ending June 30, 2026, with 7.30% growth. This brings the company's revenue in the last twelve months to 6.82B, up 6.09% year-over-year. In the year 2025, Zhejiang CONBA Pharmaceutical had annual revenue of 6.47B, down -0.64%.

• Revenue (ttm): 6.82B
• Revenue Growth: +6.09%
• P/S Ratio: 1.63
• Revenue / Employee: 870.99K
• Employees: 7,826
• Market Cap: 11.14B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.47B	-41.73M	-0.64%
Dec 31, 2024	6.52B	-217.63M	-3.23%
Dec 31, 2023	6.73B	732.35M	12.20%
Dec 31, 2022	6.00B	-567.74M	-8.64%
Dec 31, 2021	6.57B	659.17M	11.16%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error